Win Medica Pharmaceutical S.A.

3 trials Commercial sponsor Merged from 2 name variants

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

1 Countries active

4 Unique IMPs

100% Results reported

Phase III

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Coronary artery disease 1

Top IMPs

FLECAINIDE ACETATE 2 AMIODARONE HYDROCHLORIDE 1 AMLODIPINE, IRBESARTAN 1

All trials

3 total

Effects of the combination of two drugs called irbesartan and amlodipine, in one pill in patients with high blood pressure. Ended

2024-511705-31-00 Phase III 1 country AMLODIPINE, IRBESARTAN
A perspective multicenter randomized clinical trial for the safety and efficacy of flecainide compared to amiodorone for the conversion of p… Ended

2024-519233-33-00 Phase III 1 country AMIODARONE HYDROCHLORIDE; FLECAINIDE ACETATE
Comparison of the effectiveness of IntraVenous FLECainide plus oral ranolazine versus intravenous flecainide alone in the cardioversion of r… Ended

2024-514677-22-00 Phase III 1 country FLECAINIDE ACETATE

Showing 1–3 of 3 trials

← All sponsors A–Z